Evolving Trends in Interventional Cardiology: Endovascular Options for Congenital Disease in Adults

Canadian Journal of Cardiology

Volumn 30, Issue 1, 2014, Pages 75-86

  Wilson, William ^a   Osten, Mark ^a   Benson, Lee ^b   Horlick, Eric ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT DISEASE; AORTA COARCTATION; AORTIC VALVE REPAIR; BLOOD VESSEL SHUNT; CARDIAC CONDUIT; CARDIOLOGY; CONGENITAL HEART DISEASE; FALSE ANEURYSM; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; PATENT DUCTUS ARTERIOSUS; PATENT FORAMEN OVALE; PULMONARY ARTERY STENOSIS; PULMONARY VALVE; PULMONARY VALVE STENOSIS; PULMONARY VALVULOPLASTY; REVIEW; RIGHT VENTRICLE TO PULMONARY ARTERY CONDUIT; TRICUSPID VALVE DISEASE;

EID: 84890829841     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.11.006     Document Type: Review

References (92)

1. Gilboa S.M., Salemi J.L., Nembhard W.N., Fixler D.E., Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation 2010, 122:2254-2263.
2. Boneva R.S., Botto L.D., Moore C.A., et al. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 2001, 103:2376-2381.
3. Stuart A.G. Changing lesion demographics of the adult with congenital heart disease: an emerging population with complex needs. Future Cardiol 2012, 8:305-313.
4. Glockler M., Halbfass J., Koch A., et al. Multimodality 3D-roadmap for cardiovascular interventions in congenital heart disease - a single centre retrospective analysis of 78 cases. Catheter Cardiovasc Interv 2013, 82:436-442.
5. Fagan T., Kay J., Carroll J., Neubauer A. 3-D guidance of complex pulmonary artery stent placement using reconstructed rotational angiography with live overlay. Catheter Cardiovasc Interv 2012, 79:414-421.
6. Berman D.P., Khan D.M., Gutierrz Y., Zahn E.M. The use of three-dimensional rotational angiography to assess the pulmonary circulation following cavopulmonary connection in patients with single ventricle. Catheter Cardiovasc Interv 2012, 80:922-930.
7. Noble S., Miró J., Yong G., et al. Rapid pacing rotational angiography with three-dimensional reconstruction: use and benefits in structural heart disease interventions. EuroIntervention 2009, 5:244-249.
8. Silversides C.K., Poirier N., Taylor D., et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: shunt lesions. Can J Cardiol 2010, 26:e70-e79.
9. Amplatzer Septal Occluder and delivery system: instructions for use. Available at: Accessed November 2,2013. http://professional.sjm.com/professional/resources/ifu/sh/asd-closure.
10. Windram J.D., Siu S.C., Wald R.M., Silversides C.K. New directives in cardiac imaging: imaging the adult with congenital heart disease. Can J Cardiol 2013, 29:830-840.
11. Freixa X., Garceau P., Asgar A.W. First experience with the new GORE septal occluder for the closure of multiple atrial septal defects. Catheter Cardiovasc Interv 2013, 81:1238-1242.
12. Kotowycz M.A., Therrien J., Ionescu-Ittu R., et al. Long-term outcomes after surgical versus transcatheter closure of atrial septal defects in adults. JACC Cardiovasc Interv 2013, 6:497-503.
13. Du Z.D., Hijazi Z.M., Kleinman C.S., et al. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. JAm Coll Cardiol 2002, 39:1836-1844.
14. Majunke N., Bialkowski J., Wilson N., et al. Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol 2009, 103:550-554.
15. St Jude Medical. Amplatzer Atrial Septal Occluder Executive Summary.May 24, 2012. Available at: Accessed November 2,2013. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM304944.pdf.
16. Moore J., Hegde S., El-Said H., et al. Transcatheter device closure of atrial septal defects. A safety review. JACC Cardiovasc Interv 2013, 6:433-442.
17. Divekar A., Gaamanngwe T., Shaikh N., et al. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. JAm Coll Cardiol 2005, 45:1213-1218.
18. Yared K., Baggish A.L., Solis J., et al. Advances in cardiovascular imaging. Circ Cardiovasc Imaging 2009, 2:141-149.
19. Schubert S., Peters B., Abdul-Khaliq H., et al. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv 2005, 64:333-339.
20. Lock J.E., Block P.C., McKay R.G., Baim D.S., Keane J.F. Transcatheter closure of ventricular septal defects. Circulation 1988, 78:361-368.
21. Carminati M., Butera G., Chessa M., et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J 2007, 28:2361-2368.
22. Butera G., Carminati M., Chessa M., et al. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. JAm Coll Cardiol 2007, 50:1189.
23. Holzer R., Balzer D., Cao Q.L., et al. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. JAm Coll Cardiol 2004, 43:1257-1263.
24. Knauth A.L., Lock J.E., Perry S.B., et al. Transcatheter device closure of congenital and post-operative residual ventricular septal defects. Circulation 2004, 110:501-507.
25. Al-Kashkari W., Balan P., Kavinsky C.J., et al. Percutaneous device closure of congenital and iatrogenic ventricular septal defects in adults. Catheter Cardiovasc Interv 2011, 77:260-267.
26. El Said H.G., Bratincsak A., Gordon B.M., Moore J.W. Closure of perimembranous ventricular septal defects with aneurysmal tissue using the amplazter duct occluder I: Lessons learned and medium-term follow-up. Catheter Cardiovasc Interv 2012, 80:895-903.
27. Velasco-Sanchez D., Tzikas A., Ibrahim R., Miro J. Transcatheter closure of perimembranous ventricular septal defects: initial human experience with the Amplatzer membranous VSD occluder 2. Catheter Cardiovasc Interv 2013, 82:474-479.
28. Yang J., Yang L., Wan Y. Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes. Eur Heart J 2010, 31:2238-2245.
29. Pass R.H., Hijazi Z., Hsu D.T., Lewis V., Hellenbrand W.E. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. JAm Coll Cardiol 2004, 44:513-519.
30. Warnes C.A., Williams R.G., Bashore T.M., et al. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 2008, 118:e714.
31. Krisnanda C., Menahem S., Lane G.K. Intravascular stent implantation for the management of pulmonary artery stenosis. Heart Lung Circ 2013, 22:56-70.
32. Law M.A., Shamszad P., Nugent A.W., et al. Pulmonary artery stents: long-term follow up. Catheter Cardiovasc Interv 2010, 75:757-764.
33. Stapleton G.E., Hamzeh R., Mullins C.E., et al. Simultaneous stent implantation to treat bifurcation stenoses in the pulmonary arteries: initial results and long-term follow-up. Catheter Cardiovasc Interv 2009, 73:557-563.
34. Mitropoulos F.A., Laks H., Kapadia N., et al. Intraoperative pulmonary artery stenting: an alternative technique for the management of pulmonary artery stenosis. Ann Thorac Surg 2007, 84:1338-1341.
35. Roche S.L., Silversides C. Hypertension, obesity and coronary artery disease in the survivors of congenital heart disease. Can J Cardiol 2013, 29:841-848.
36. Roifman I., Therrien J., Ionescu-Ittu R., et al. Coarctation of the aorta and coronary disease. Fact or fiction?. Circulation 2012, 126:16-21.
37. Singer M.I., Rowen M., Dorsey T.J. Transluminal aortic balloon angioplasty for coarctation of the aorta in the newborn. Am Heart J 1982, 103:131-132.
38. Golden A.B., Hellenbrand W.E. Coarctation of the aorta: stenting in children and adults. Catheter Cardiovasc Interv 2007, 69:289-299.
39. Carr J.A. The results of catheter-based therapy compared with surgical repair of adult aortic coarctation. JAm Coll Cardiol 2006, 47:1101-1107.
40. Forbes T.J., Kim D.W., Du W., et al. Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). JAm Coll Cardiol 2011, 58:2664-2674.
41. Rodes-Cabau J., Miro J., Dancea A., et al. Comparison of surgical and transcatheter treatment for native coarctation of the aorta in patients > or= 1 year old. The Quebec Native Coarctation of the Aorta study. Am Heart J 2007, 154:186-192.
42. O'Laughlin M.P., Perry S.B., Lock J.E., Mullins C.E. Use of endovascular stents in congenital heart disease. Circulation 1991, 83:1923-1939.
43. Rosenthal E. Coarctation of the aorta from fetus to adult: curable condition or life long disease process?. Heart 2005, 91:1495-1502.
44. Chakrabarti S., Kenny D., Morgan G., et al. Balloon expandable stent implantation for native and recurrent coarctation of the aorta-prospective computed tomography assessment of stent integrity, aneurysm formation and stenosis relief. Heart 2010, 96:1212-1216.
45. Sadiq M., Rehman A., Qureshi A., Qureshi S. Covered stents in the management of native coarctation of the aorta - intermediate and long-term follow-up. Catheter Cardiovasc Interv 2013, 82:511-518.
46. Tzifa A., Ewert P., Brzezinzka-Rajszys G., et al. Covered Cheatham-Platinum stents for aortic coarctation: early and intermediate-term results. JAm Coll Cardiol 2006, 47:1457-1463.
47. Butera G., Heles M., MacDonald S.T., Carminati M. Aortic coarctation complicated by wall aneurysm: the role of covered stents. Catheter Cardiovasc Interv 2011, 78:926-932.
48. Tanous D., Collins N., Dehghani P., Benson L.N., Horlick E.M. Covered stents in the management of coarctation of the aorta in the adult: initial results and 1-year angiographic and hemodynamic follow-up. Int J Cardiol 2010, 140:287-295.
49. Ringel R.E., Vincent J., Jenkins K.J., et al. Acute outcome of stent therapy for coarctation of the aorta: results of the coarctation of the aorta stent trial. Catheter Cardiovasc Interv 2013, 82:503-510.
50. Goldstein B.H., Hirsch R., Zussman M.E., et al. Percutaneous balloon-expandable covered stent implantation for treatment of traumatic aortic injury in children and adolescents. Am J Cardiol 2012, 110:1541-1545.
51. Krasemann T., Bano M., Rosenthal E., Qureshi S.A. Results of stent implantation for native and recurrent coarctation of the aorta- follow-up of up to 13 years. Catheter Cardiovasc Interv 2011, 78:405-412.
52. Schranz D., Zartner P., Michel-Behnke I., Akinturk H. Bioabsorbable metal stents for percutaneous treatment of critical recoarctation of the aorta in a newborn. Catheter Cardiovasc Interv 2006, 67:671-673.
53. Sandhu S.K., Lloyd T.R., Crowley D.C., Beekman R.H. Effectiveness of balloon valvuloplasty in the young adult with congenital aortic stenosis. Cathet Cardiovasc Diagn 1995, 36:122-127.
54. Brown D.W., Dipilato A.E., Chong E.C., Lock J.E., McElhinney D.B. Aortic valve reinterventions after balloon aortic valvuloplasty for congenital aortic stenosis intermediate and late follow-up. JAm Coll Cardiol 2010, 56:1740-1749.
55. Maskatia S.A., Ing F.F., Justino H., et al. Twenty-five year experience with balloon aortic valvuloplasty for congenital aortic stenosis. Am J Cardiol 2011, 108:1024-1028.
56. Chen C.R., Cheng T.O., Huang T., et al. Percutaneous balloon valvuloplasty for pulmonic stenosis in adolescents and adults. NEngl J Med 1996, 335:21-25.
57. Fawzy M.E., Hassan W., Fadel B.M., et al. Long-term results (up to 17 years) of pulmonary balloon valvuloplasty in adults and its effects on concomitant severe infundibular stenosis and tricuspid regurgitation. Am Heart J 2007, 153:433-438.
58. Kaul U.A., Singh B., Tyagi S., et al. Long-term results after balloon pulmonary valvuloplasty in adults. Am Heart J 1993, 126:1152-1155.
59. Dancea A., Justino H., Martucci G. Catheter intervention for congenital heart disease at risk of circulatory failure. Can J Cardiol 2013, 29:786-795.
60. Boudjemline Y., Brugada G., Van-Aerschot I., et al. Outcomes and safety of transcatheter pulmonary valve replacement in patients with large patched right ventricular outflow tracts. Arch Cardiovasc Dis 2012, 105:404-413.
61. Momenah T.S., Oakley R.E., Al Najashi K., et al. Extended application of percutaneous pulmonary valve implantation. JAm Coll Cardiol 2009, 53:1859-1863.
62. Baumgartner H., Bonhoeffer P., De Groot N.M., et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010, 31:2915-2957.
63. McElhinney D.B., Hellenbrand W.E., Zahn E.M., et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 2010, 122:507-516.
64. Sridharan S., Coats L., Khambadkone S., et al. Images in cardiovascular medicine. Transcatheter right ventricular outflow tract intervention: the risk to the coronary circulation. Circulation 2006, 113:e394.
65. Nordmeyer J., Lurz P., Khambadkone S., et al. Pre-stenting with a bare metal stent before percutaneous pulmonary valve implantation: acute and one year outcomes. Heart 2011, 97:118-123.
66. Rodes-Cabau J., Houde C., Perron J., et al. Delayed improvement in valve haemodynamic performance after percutaneous pulmonary valve implantation. Ann Thorac Surg 2008, 85:1787-1788.
67. Eicken A., Ewert P., Hager A., et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J 2011, 32:1260-1265.
68. Lurz P., Coats L., Khambadkone S., et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008, 117:1964-1972.
69. Butera G., Milanesi O., Spadoni I., et al. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian society of pediatric cardiology. Catheter Cardiovasc Interv 2013, 81:310-316.
70. Boone R.H., Webb J.G., Horlick E., et al. Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter Cardiovasc Interv 2010, 75:286-294.
71. Kenny D., Hijazi Z.M., Kar S., et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. JAm Coll Cardiol 2011, 58:2248-2256.
72. Haas N.A., Moyisch A., Neudorf U., et al. Percutaneous implantation of the Edwards Sapien pulmonic valve: initial results in the first 22 patients. Clin Res Cardiol 2013, 102:119-128.
73. Odemis E., Guzeltas A., Saygi M., et al. Percutaneous pulmonary valve implantation using Edwards Sapien transcatheter heart valve in different types of conduits: initial results of a single centre experience. Congenit Heart Dis 2013, 8:411-417.
74. Guccione P., Milanesi O., Hijazi Z.M., Pongiglione G. Transcatheter pulmonary valve implantation in native pulmonary outflow tract using the Edwards Sapien transcatheter heart valve. Eur J Cardiothorac Surg 2012, 41:1192-1194.
75. Bertels R.A., Blom N.A., Schalij M.J. Edwards SAPIEN transcatheter heart valve in native pulmonary position. Heart 2010, 96:661.
76. Gillespie M.J., Dori Y., Harris M.A., et al. Bilateral branch pulmonary artery Melody Valve implantation for treatment of complex right ventricular outflow tract dysfunction in a high risk patient. Circ Catheter Interv 2011, 4:e21-e23.
77. Kang I., Redington A.N., Benson L.N., et al. Differential regurgitation in branch pulmonary arteries after repair of tetralogy of Fallot. Circulation 2003, 107:2938-2943.
78. Amahzoune B., Szymansky C., Fabiani J., Zegdi R. Anew endovascular size reducer for large pulmonary outflow tract. Eur J Cardiothorac Surg 2010, 37:730-732.
79. Boudjemline Y., Laborde F., Pineau E., et al. Expandable right ventricular-to-pulmonary artery conduit: an animal study. Pediatr Res 2006, 59:773-777.
80. Coats L., Khambadkone S., Derrick G., et al. Physiological and clinical consequences of relief of right ventricular outflow tract obstruction late after repair of congenital heart defects. Circulation 2006, 113:2037-2044.
81. Abdullah I., Ramirez F.B., McElhinney D.B., et al. Modification of a stented bovine jugular vein conduit (Melody Valve) for surgical mitral valve replacement. Ann Thorac Surg 2012, 94:e97-e98.
82. Roberts P.A., Boudjemline Y., Cheatham J.P., et al. Percutaneous tricuspid valve replacement in congenital and acquired heart disease. JAm Coll Cardiol 2011, 58:117-122.
83. Van Garsse M.D., Ter Bekke R.M., van Ommen V.G. Percutaneous transcatheter valve-in-valve implantation in a stenosed tricuspid valve bioprosthesis. Circulation 2011, 123:e219-2.
84. Dave A.S., Aboulhosn J., Child J.S., Shivkumar K. Trans-conduit puncture for catheter ablation of atrial tachycardia in a patient with extra-cardiac Fontan palliation. Heart Rhthym 2010, 7:413-416.
85. Aboulhosn J., Child J.S. The adult with a Fontan operation. Curr Cardiol Rep 2007, 9:331-335.
86. Mavroudis C., Deal B.J., Backer C.L., et al. Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes. Ann Thorac Surg 2007, 84:1457-1465.
87. Ebeid M.R., Gaymes C.H. Catheter conversion of classic glenn to bidirectional glenn with closure of left central shunt years after surgical attempts. Catheter Cardiovasc Interv 2013, 82:E688-E693.
88. Butcher C.J., Plymen C.M., Walker F. Anovel and unique treatment for right ventricular inflow obstruction in a patient with a Bjork modification of the Fontan palliation before pregnancy. Cardiol Young 2010, 20:337-339.
89. Girona J., Marti G., Betrian P., Gran F., Casaldaliga J. Percutaneous embolization of vascular fistulas using coils or Amplatzer Vascular plugs. Rev Esp Cardiol 2009, 62:765-773.
90. Park S.C., Neches W.H., Mathews R.A., et al. Haemodynamic function after the Mustard operation for transposition of the great arteries. Am J Cardiol 1983, 51:1514-1519.
91. Bu'Lock F.A., Tometzki A., Kitchiner D.J., et al. Balloon expandable stents for systemic venous pathway stenosis late after Mustard's operation. Heart 1998, 79:225-229.
92. Ward C.J., Mullins C.E., Nihill M.R., Grifka R.G., Vick G.W. Use of intravascular stents in systemic venous and systemic venous baffle obstructions. Short-term follow-up results. Circulation 1995, 91:2948-2954.